drugset / Trial / NCT04447534

Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19

NCT04447534 ↗

Phase 3 Completed 191 enrolled Tanta University
RandomizedParallel-groupDouble-blindTreatment

Summary

we want to investigate if zinc supplementation enhance the clinical efficacy of chloroquine in treatment of COVID-19.

Timeline

Start
2020-06-23
Primary completion
2020-07-15
Completion
2020-08-15

Outcome

Missed primary endpoint

paper Clinical recovery after 28 days was achieved by 79.2% in the zinc group and 77.9% in zinc-free treatment group, without any significant difference (p = 0.969). PMID 33247380 ↗

paper The need for mechanical ventilation and the overall mortality rates did not show any significant difference between the 2 groups either (p = 0.537 and 0.986, respectively). PMID 33247380 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Chloroquine Small molecule — —
Subject Hydroxychloroquine Small molecule — —
Subject Zinc Sulfate Unknown — —

Indications